Generic drug makerLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of Cipla. FDA records under 2 spellings of its name, each linked to the record. See the Cipla group view.
As of Nov 15, 2026, FDA's public records list InvaGen Pharmaceuticals, Inc. with 70 drug applications and 11 drug recalls. The most recent is a drug recall dated Nov 17, 2023: Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufa….
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
